People · Operator

Brad Fiedler

Named in public records as an officer, director or promoter · active 2021–2023 · Other Health Care, Other Technology

2
Companies
5
Filings
$66.7M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Theator Inc.Other Health CareSeries B$38.2M$291.9M2021
PartsTech, Inc.Other TechnologySeries A$28.5M$131.9M2021
Operator network

Brad Fiedler at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Gigi Levy-Weiss · 3 companies · 1 sharedGigi Levy-WeissDotan Asselmann · 1 companies · 1 sharedDotan AsselmannDotan Asslemann · 1 companies · 1 sharedDotan AsslemannKavi Vyas · 1 companies · 1 sharedKavi VyasTamir Wolf · 1 companies · 1 sharedTamir WolfShaun Healey · 5 companies · 1 sharedShaun HealeyAndreas Andorfer · 1 companies · 1 sharedAndreas AndorferCarl John Gustafson · 1 companies · 1 sharedCarl John Gustafs…Daniel Briere · 1 companies · 1 sharedDaniel BriereEnrico Manuele · 1 companies · 1 sharedEnrico ManueleErik St. Pierre · 1 companies · 1 sharedErik St. PierreGregory Kirber · 1 companies · 1 sharedGregory KirberTim John Keebler · 1 companies · 1 sharedTim John KeeblerTheator Inc. · $38.2M raisedTheator Inc.PartsTech, Inc. · $28.5M raisedPartsTech, Inc.Brad FiedlerBF
Brad Fiedler Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Brad Fiedler on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Shaun Healey15
Gigi Levy-Weiss13
Tim John Keebler11
Andreas Andorfer11
Erik St. Pierre11
Gregory Kirber11
Daniel Briere11
Enrico Manuele11
Kavi Vyas11
Dotan Asselmann11
Tamir Wolf11
Dotan Asslemann11
Carl John Gustafson11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.